WM, L., T, J., J, C., K, C., MW, B., R, S., . . . CA, P. (2026). Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm. Journal of the National Cancer Institute, 118(6), 1081. https://doi.org/10.1093/jnci/djag064
Chicago Style (17th ed.) CitationWM, Linehan, Jemielita T, Cornell J, Chen K, Ball MW, Srinivasan R, Liu Y, Perini RF, and Pinto CA. "Belzutifan Efficacy in Von Hippel-Lindau Disease-associated Renal Cell Carcinoma Versus Natural History Control Arm." Journal of the National Cancer Institute 118, no. 6 (2026): 1081. https://doi.org/10.1093/jnci/djag064.
MLA (9th ed.) CitationWM, Linehan, et al. "Belzutifan Efficacy in Von Hippel-Lindau Disease-associated Renal Cell Carcinoma Versus Natural History Control Arm." Journal of the National Cancer Institute, vol. 118, no. 6, 2026, p. 1081, https://doi.org/10.1093/jnci/djag064.
